Fennec Pharmaceuticals Stock Alpha and Beta Analysis

FRX Stock  CAD 10.63  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Fennec Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Fennec Pharmaceuticals over a specified time horizon. Remember, high Fennec Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Fennec Pharmaceuticals' market risk premium analysis include:
Beta
(1.01)
Alpha
(0.04)
Risk
3.01
Sharpe Ratio
(0.07)
Expected Return
(0.22)
Please note that although Fennec Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Fennec Pharmaceuticals did 0.04  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Fennec Pharmaceuticals stock's relative risk over its benchmark. Fennec Pharmaceuticals has a beta of 1.01  . As the market becomes more bullish, returns on owning Fennec Pharmaceuticals are expected to decrease slowly. On the other hand, during market turmoil, Fennec Pharmaceuticals is expected to outperform it slightly. At this time, Fennec Pharmaceuticals' Enterprise Value Over EBITDA is very stable compared to the past year. As of the 28th of December 2025, Enterprise Value Multiple is likely to grow to 48.18, though Book Value Per Share is likely to grow to (0.20).

Fennec Pharmaceuticals Quarterly Cash And Equivalents

20.29 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Fennec Pharmaceuticals Backtesting, Fennec Pharmaceuticals Valuation, Fennec Pharmaceuticals Correlation, Fennec Pharmaceuticals Hype Analysis, Fennec Pharmaceuticals Volatility, Fennec Pharmaceuticals History and analyze Fennec Pharmaceuticals Performance.
To learn how to invest in Fennec Stock, please use our How to Invest in Fennec Pharmaceuticals guide.

Fennec Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Fennec Pharmaceuticals market risk premium is the additional return an investor will receive from holding Fennec Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Fennec Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Fennec Pharmaceuticals' performance over market.
α-0.04   β-1.01

Fennec Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Fennec Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Fennec Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Fennec Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Fennec Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fennec Pharmaceuticals shares will generate the highest return on investment. By understating and applying Fennec Pharmaceuticals stock market price indicators, traders can identify Fennec Pharmaceuticals position entry and exit signals to maximize returns.

Fennec Pharmaceuticals Return and Market Media

The median price of Fennec Pharmaceuticals for the period between Mon, Sep 29, 2025 and Sun, Dec 28, 2025 is 11.59 with a coefficient of variation of 7.82. The daily time series for the period is distributed with a sample standard deviation of 0.91, arithmetic mean of 11.6, and mean deviation of 0.74. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Can Fennec Pharmaceuticals Inc. stock maintain growth trajectory - Market Risk Summary Technical Buy Zone Confirmations - newser.com
10/23/2025
2
Will Fennec Pharmaceuticals Inc. stock benefit from Fed rate cuts - Quarterly Portfolio Report Expert Curated Trade Setups - newser.com
11/11/2025
3
Fennec Pharmaceuticals Sells Shares To Raise 35 Million - Finimize
11/14/2025
4
Fennec Pharmaceuticals Announces Underwriting Agreement for Share Offering - TipRanks
11/17/2025
5
Fennec Pharmaceuticals Closes 5M Private Offering in Canada - MSN
11/20/2025
6
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - Yahoo Finance
11/26/2025
7
Fennec Pharmaceuticals Stock Price Passes Below Fifty Day Moving Average - Heres What Happened - MarketBeat
12/03/2025
8
Fennec Pharma announces City of Hope PEDMARK trial in metastatic testicular tumors FENC Stock News - Stock Titan
12/09/2025
9
Risk-Controlled Trading Report - news.stocktradersdaily.com
12/12/2025
10
Is Fennec Pharmaceuticals Inc. stock cheap at current valuation - 2025 Geopolitical Influence Reliable Intraday Trade Plans - ulpravda.ru
12/19/2025

About Fennec Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Fennec or other stocks. Alpha measures the amount that position in Fennec Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 2025 (projected)
Interest Debt Per Share1.290.860.9
Revenue Per Share0.81.741.83
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fennec Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fennec Pharmaceuticals' short interest history, or implied volatility extrapolated from Fennec Pharmaceuticals options trading.

Build Portfolio with Fennec Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:
Fennec Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Fennec Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Fennec Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...